The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Abiraterone Acetate API Market Research Report 2025
Synopsis
It has a white powder appearance, the molecular formula is C26H33NO2, and CAS number is 154229-18-2.
The global Abiraterone Acetate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Abiraterone Acetate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abiraterone Acetate API.
Report Scope
The Abiraterone Acetate API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Abiraterone Acetate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abiraterone Acetate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cipla
Sterling S.P.A. IT
Scion Pharm Taiwan
HETERO
Aspen Bio Pharma Labs
Aurisco Pharmaceutical
Farmhispania Group
Tapi Teva
Shilpa Medicare Limited
Qilu Pharmaceutial
Shandong Chuangxin Pharmaceutical Research and Development
Zhejiang Xianju Junye Pharmaceutical
Wuhan Sunrise Technology Development
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Abiraterone Acetate Tablets
Abiraterone Acetate Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Abiraterone Acetate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Abiraterone Acetate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Abiraterone Acetate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
It has a white powder appearance, the molecular formula is C26H33NO2, and CAS number is 154229-18-2.
The global Abiraterone Acetate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Abiraterone Acetate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abiraterone Acetate API.
Report Scope
The Abiraterone Acetate API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Abiraterone Acetate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abiraterone Acetate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cipla
Sterling S.P.A. IT
Scion Pharm Taiwan
HETERO
Aspen Bio Pharma Labs
Aurisco Pharmaceutical
Farmhispania Group
Tapi Teva
Shilpa Medicare Limited
Qilu Pharmaceutial
Shandong Chuangxin Pharmaceutical Research and Development
Zhejiang Xianju Junye Pharmaceutical
Wuhan Sunrise Technology Development
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Abiraterone Acetate Tablets
Abiraterone Acetate Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Abiraterone Acetate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Abiraterone Acetate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Abiraterone Acetate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Abiraterone Acetate API Market Overview
1.1 Product Definition
1.2 Abiraterone Acetate API Segment by Type
1.2.1 Global Abiraterone Acetate API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Abiraterone Acetate API Segment by Application
1.3.1 Global Abiraterone Acetate API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Abiraterone Acetate Tablets
1.3.3 Abiraterone Acetate Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Abiraterone Acetate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Abiraterone Acetate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Abiraterone Acetate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Abiraterone Acetate API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Abiraterone Acetate API Production Market Share by Manufacturers (2019-2024)
2.2 Global Abiraterone Acetate API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Abiraterone Acetate API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Abiraterone Acetate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Abiraterone Acetate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Abiraterone Acetate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Abiraterone Acetate API, Product Offered and Application
2.8 Global Key Manufacturers of Abiraterone Acetate API, Date of Enter into This Industry
2.9 Abiraterone Acetate API Market Competitive Situation and Trends
2.9.1 Abiraterone Acetate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Abiraterone Acetate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Abiraterone Acetate API Production by Region
3.1 Global Abiraterone Acetate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Abiraterone Acetate API Production Value by Region (2019-2030)
3.2.1 Global Abiraterone Acetate API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Abiraterone Acetate API by Region (2025-2030)
3.3 Global Abiraterone Acetate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Abiraterone Acetate API Production by Region (2019-2030)
3.4.1 Global Abiraterone Acetate API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Abiraterone Acetate API by Region (2025-2030)
3.5 Global Abiraterone Acetate API Market Price Analysis by Region (2019-2024)
3.6 Global Abiraterone Acetate API Production and Value, Year-over-Year Growth
3.6.1 North America Abiraterone Acetate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Abiraterone Acetate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Abiraterone Acetate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Abiraterone Acetate API Production Value Estimates and Forecasts (2019-2030)
4 Abiraterone Acetate API Consumption by Region
4.1 Global Abiraterone Acetate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Abiraterone Acetate API Consumption by Region (2019-2030)
4.2.1 Global Abiraterone Acetate API Consumption by Region (2019-2024)
4.2.2 Global Abiraterone Acetate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Abiraterone Acetate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Abiraterone Acetate API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Abiraterone Acetate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Abiraterone Acetate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Abiraterone Acetate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Abiraterone Acetate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Abiraterone Acetate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Abiraterone Acetate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Abiraterone Acetate API Production by Type (2019-2030)
5.1.1 Global Abiraterone Acetate API Production by Type (2019-2024)
5.1.2 Global Abiraterone Acetate API Production by Type (2025-2030)
5.1.3 Global Abiraterone Acetate API Production Market Share by Type (2019-2030)
5.2 Global Abiraterone Acetate API Production Value by Type (2019-2030)
5.2.1 Global Abiraterone Acetate API Production Value by Type (2019-2024)
5.2.2 Global Abiraterone Acetate API Production Value by Type (2025-2030)
5.2.3 Global Abiraterone Acetate API Production Value Market Share by Type (2019-2030)
5.3 Global Abiraterone Acetate API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Abiraterone Acetate API Production by Application (2019-2030)
6.1.1 Global Abiraterone Acetate API Production by Application (2019-2024)
6.1.2 Global Abiraterone Acetate API Production by Application (2025-2030)
6.1.3 Global Abiraterone Acetate API Production Market Share by Application (2019-2030)
6.2 Global Abiraterone Acetate API Production Value by Application (2019-2030)
6.2.1 Global Abiraterone Acetate API Production Value by Application (2019-2024)
6.2.2 Global Abiraterone Acetate API Production Value by Application (2025-2030)
6.2.3 Global Abiraterone Acetate API Production Value Market Share by Application (2019-2030)
6.3 Global Abiraterone Acetate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Cipla
7.1.1 Cipla Abiraterone Acetate API Corporation Information
7.1.2 Cipla Abiraterone Acetate API Product Portfolio
7.1.3 Cipla Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Cipla Main Business and Markets Served
7.1.5 Cipla Recent Developments/Updates
7.2 Sterling S.P.A. IT
7.2.1 Sterling S.P.A. IT Abiraterone Acetate API Corporation Information
7.2.2 Sterling S.P.A. IT Abiraterone Acetate API Product Portfolio
7.2.3 Sterling S.P.A. IT Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Sterling S.P.A. IT Main Business and Markets Served
7.2.5 Sterling S.P.A. IT Recent Developments/Updates
7.3 Scion Pharm Taiwan
7.3.1 Scion Pharm Taiwan Abiraterone Acetate API Corporation Information
7.3.2 Scion Pharm Taiwan Abiraterone Acetate API Product Portfolio
7.3.3 Scion Pharm Taiwan Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Scion Pharm Taiwan Main Business and Markets Served
7.3.5 Scion Pharm Taiwan Recent Developments/Updates
7.4 HETERO
7.4.1 HETERO Abiraterone Acetate API Corporation Information
7.4.2 HETERO Abiraterone Acetate API Product Portfolio
7.4.3 HETERO Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 HETERO Main Business and Markets Served
7.4.5 HETERO Recent Developments/Updates
7.5 Aspen Bio Pharma Labs
7.5.1 Aspen Bio Pharma Labs Abiraterone Acetate API Corporation Information
7.5.2 Aspen Bio Pharma Labs Abiraterone Acetate API Product Portfolio
7.5.3 Aspen Bio Pharma Labs Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Aspen Bio Pharma Labs Main Business and Markets Served
7.5.5 Aspen Bio Pharma Labs Recent Developments/Updates
7.6 Aurisco Pharmaceutical
7.6.1 Aurisco Pharmaceutical Abiraterone Acetate API Corporation Information
7.6.2 Aurisco Pharmaceutical Abiraterone Acetate API Product Portfolio
7.6.3 Aurisco Pharmaceutical Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Aurisco Pharmaceutical Main Business and Markets Served
7.6.5 Aurisco Pharmaceutical Recent Developments/Updates
7.7 Farmhispania Group
7.7.1 Farmhispania Group Abiraterone Acetate API Corporation Information
7.7.2 Farmhispania Group Abiraterone Acetate API Product Portfolio
7.7.3 Farmhispania Group Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Farmhispania Group Main Business and Markets Served
7.7.5 Farmhispania Group Recent Developments/Updates
7.8 Tapi Teva
7.8.1 Tapi Teva Abiraterone Acetate API Corporation Information
7.8.2 Tapi Teva Abiraterone Acetate API Product Portfolio
7.8.3 Tapi Teva Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Tapi Teva Main Business and Markets Served
7.7.5 Tapi Teva Recent Developments/Updates
7.9 Shilpa Medicare Limited
7.9.1 Shilpa Medicare Limited Abiraterone Acetate API Corporation Information
7.9.2 Shilpa Medicare Limited Abiraterone Acetate API Product Portfolio
7.9.3 Shilpa Medicare Limited Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Shilpa Medicare Limited Main Business and Markets Served
7.9.5 Shilpa Medicare Limited Recent Developments/Updates
7.10 Qilu Pharmaceutial
7.10.1 Qilu Pharmaceutial Abiraterone Acetate API Corporation Information
7.10.2 Qilu Pharmaceutial Abiraterone Acetate API Product Portfolio
7.10.3 Qilu Pharmaceutial Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Qilu Pharmaceutial Main Business and Markets Served
7.10.5 Qilu Pharmaceutial Recent Developments/Updates
7.11 Shandong Chuangxin Pharmaceutical Research and Development
7.11.1 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Corporation Information
7.11.2 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Product Portfolio
7.11.3 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Shandong Chuangxin Pharmaceutical Research and Development Main Business and Markets Served
7.11.5 Shandong Chuangxin Pharmaceutical Research and Development Recent Developments/Updates
7.12 Zhejiang Xianju Junye Pharmaceutical
7.12.1 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Corporation Information
7.12.2 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Product Portfolio
7.12.3 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Zhejiang Xianju Junye Pharmaceutical Main Business and Markets Served
7.12.5 Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates
7.13 Wuhan Sunrise Technology Development
7.13.1 Wuhan Sunrise Technology Development Abiraterone Acetate API Corporation Information
7.13.2 Wuhan Sunrise Technology Development Abiraterone Acetate API Product Portfolio
7.13.3 Wuhan Sunrise Technology Development Abiraterone Acetate API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Wuhan Sunrise Technology Development Main Business and Markets Served
7.13.5 Wuhan Sunrise Technology Development Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Abiraterone Acetate API Industry Chain Analysis
8.2 Abiraterone Acetate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Abiraterone Acetate API Production Mode & Process
8.4 Abiraterone Acetate API Sales and Marketing
8.4.1 Abiraterone Acetate API Sales Channels
8.4.2 Abiraterone Acetate API Distributors
8.5 Abiraterone Acetate API Customers
9 Abiraterone Acetate API Market Dynamics
9.1 Abiraterone Acetate API Industry Trends
9.2 Abiraterone Acetate API Market Drivers
9.3 Abiraterone Acetate API Market Challenges
9.4 Abiraterone Acetate API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
